Ovide .5% lotion

OVIDE Lotion is indicated for patients infected with Pediculus humanus capitis (head lice and their ova) of the scalp hair.

OVIDE Lotion is contraindicated for neonates and infants because their scalps are more permeable and may have increased absorption of malathion. OVIDE Lotion should also not be used on individuals known to be sensitive to malathion or any of the ingredients in the vehicle.

Consideration should be given, as part of the treatment program, to the high concentration of isopropyl alcohol in the vehicle.

Malathion, although a weaker cholinesterase inhibitor than some other organophosphates, may be expected to exhibit the same symptoms of cholinesterase depletion after accidental ingestion orally. If accidentally swallowed, vomiting should be induced promptly or the stomach lavaged with 5% sodium bicarbonate solution.

Severe respiratory distress is the major and most serious symptom of organophosphate poisoning requiring artificial respiration, and atropine may be needed to counteract the symptoms of cholinesterase depletion.

Repeat analyses of serum and RBC cholinesterase may assist in establishing the diagnosis and formulating a long - range prognosis.

OVIDE (malathion) Lotion, 0.5%, is supplied in bottles of 2 fl. oz. (59 mL) NDC 51672-5276-4. Store at controlled room temperature 20°-25°C (68°-77°F).

Flammable. Keep away from heat and open flame.

Manufactured for:

Taro Pharma™

a division of Taro Pharmaceuticals U.S.A., Inc.

Hawthorne, NY 10532

Manufactured by: DPT Lakewood, Inc.

Lakewood, NJ 08701 Revised July, 2005

Ovide and TaroPharma™ are trademarks of Taro Pharmaceuticals U.S.A., Inc. and/or its affiliates. PH 048-1